IPA 6 project activities
Stepwise integration of the IPA beneficiaries in the activities of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) activities and the REITOX network.
IPA 6 beneficiary countries are Albania, Bosnia–Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo*, Montenegro and Serbia.
Timetable: July 2017 – June 2019
The overall objective is to ensure that IPA II beneficiaries are able to participate effectively in the activities of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Reitox network upon accession.
The specific objective of the project is to support the approximation to and adoption of the EU acquis in the IPA II beneficiaries in the area of Rule of Law and in particular in the drug information field.
The project is structured around five expected outputs which are:
Op1: a strengthened coordination body at national level–National Drug Observatory (NDO)
Op2: an updated or new data sets and reports on drug related issues
Op3: a strengthened national Early Warning System (EWS)
Op4: an improved communication and visibility of the project
Op5: an on–going inter–institutional coordination
* This designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence. This applies to all mentions of Kosovo in this document.